What is Morgan Stanley's price target for ALHC?

Morgan Stanley's latest stated price target for Alignment Healthcare Inc. (ALHC) is $21, from its action on Mar 7, 2022.

What is Morgan Stanley's rating on ALHC?

Morgan Stanley rates ALHC Overweight, a bullish rating, as of Mar 7, 2022.

When did Morgan Stanley last change its view on ALHC?

On Mar 7, 2022, Morgan Stanley cuts its price target to $21 from $25, keeps Overweight.

Analyst firms · Morgan Stanley · ALHC

Morgan Stanley ALHC price target and rating history

Alignment Healthcare Inc. (ALHC) · Health Care

Morgan Stanley rates Alignment Healthcare Inc. (ALHC) Overweight with a $21 price target, as of its latest action on Mar 7, 2022. It has published 3 rating actions on ALHC since July 2021, including 0 upgrades and 0 downgrades.

Current rating: Overweight
Price target: $21
Median target, all firms: Too few
Actions on ALHC: 3

Morgan Stanley price target on ALHC

Morgan Stanley price target on ALHC, each point a stated target, July 2021 to March 2022.

Every Morgan Stanley rating on ALHC

Mar 7, 2022
ReiterateMorgan Stanley cuts its price target to $21 from $25, keeps Overweight
Aug 31, 2021
ReiterateMorgan Stanley cuts its price target to $25 from $38, keeps Overweight
Jul 2, 2021
ReiterateMorgan Stanley raises its price target to $38 from $36, keeps Overweight

How other firms rate ALHC

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
KeyBanc Capital Markets	Sector Weight		Oct 30, 2026
Needham	Hold		Oct 28, 2026
William Blair	Mkt Perform		Oct 9, 2026
Raymond James	Outperform	$19	Aug 3, 2026
Wolfe Research	Outperform	$24	Apr 17, 2026

Questions about Morgan Stanley and ALHC

What is Morgan Stanley's price target for ALHC?: Morgan Stanley's latest stated price target for Alignment Healthcare Inc. (ALHC) is $21, from its action on Mar 7, 2022.
What is Morgan Stanley's rating on ALHC?: Morgan Stanley rates ALHC Overweight, a bullish rating, as of Mar 7, 2022.
When did Morgan Stanley last change its view on ALHC?: On Mar 7, 2022, Morgan Stanley cuts its price target to $21 from $25, keeps Overweight.

More ALHC rating histories

All Morgan Stanley ratings ALHC news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.